Evidence map›Paper›PMID 30086574›Full record

ArticleThrombosis and haemostasis2018

Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery.

Susan A Maroney, Julie A Peterson, Wes Zwifelhofer, Nicholas D Martinez, Ke Yan, Rachel S Bercovitz, Ronald K Woods, Alan E Mast

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Thrombosis and haemostasis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Factor V east Texas variant causes bleeding in a three-generation family.Journal of thrombosis and haemostasis : JTH · 2022
    Article
  2. Developmental hemostasis in the neonatal period.World journal of pediatrics : WJP · 2022
    Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Susan A MaroneyBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
Julie A PetersonBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
Wes ZwifelhoferBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
Nicholas D MartinezBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
Ke YanDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Rachel S BercovitzBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
Ronald K WoodsDivision of Pediatric Cardiothoracic Surgery, Herma Heart Center, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States.
Alan E MastBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
Versiti Blood Center of Wisconsin · USMedical College of Wisconsin · US

Funding

Tissue Factor Pathway Inhibitor Binding Proteins on EndoR01HL068835 · NHLBI · VERSITI WISCONSIN, INC. · PI Alan E Mast · 2002 to 2026
$9.7M
NHLBI NIH HHS R01 HL068835
6 · The paper itself

Abstract

backgroundNeonates undergoing cardiopulmonary bypass (CPB) surgery to correct congenital heart defects often experience excessive bleeding. Exposure of blood to artificial materials during CPB may activate coagulation, complement and inflammatory pathways. In addition, the surgical stress placed on the haemostatic system may result in cross-activation of other plasma proteolytic cascades, which could further complicate physiological responses to the surgical procedure and post-operative recovery. Plasma protease inhibitors undergo distinct conformational changes upon interaction with proteases, and, thereby, can serve as endogenous biosensors to identify activation of the different proteolytic cascades. We tested the hypothesis that changes in the concentration and conformation of protease inhibitors regulating plasma proteolytic cascades during neonatal CPB are associated with post-operative bleeding. PATIENTS AND

methodsPlasma samples from 44 neonates were obtained at four time points across the surgical procedure. Anti-thrombin, antitrypsin, anti-chymotrypsin, anti-plasmin, C1-inhibitor and tissue factor pathway inhibitor (TFPI) concentrations and conformations were evaluated by enzyme-linked immunosorbent assay, transverse urea gradient gel electrophoresis and sodium dodecyl sulphate-polyacrylamide gel electrophoresis. RESULTS/

conclusionThe most striking changes were observed following heparin administration and were associated with the appearance of inactive forms of anti-thrombin and an increase in the plasma concentration of TFPI. Changes in anti-thrombin and TFPI remained evident throughout surgery and into the post-operative period but were not different between patients with or without post-operative bleeding. The concentration of antitrypsin decreased across surgery, but there was no significant accumulation of inactive conformations of any inhibitor besides anti-thrombin, indicating that widespread cross-activation of other plasma proteolytic cascades by coagulation proteases did not occur.

Indexed as

Cardiopulmonary BypassAnticoagulantsBlood CoagulationFemaleHemorrhageHeparinHumansInfant, NewbornLipoproteinsMalePeptide HydrolasesPlasmaPostoperative ComplicationsProtein BindingThrombinAnticoagulantsHeparinlipoprotein-associated coagulation inhibitorLipoproteinsPeptide HydrolasesThrombin

Identifiers

PMID30086574
PMCPMC6138520
OpenAlexW2886835924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.